HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bateman, A. Articles by Solomon, S. Search for Related Content PubMed PubMed Citation Articles by Bateman, A. Articles by Solomon, S. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 266, Issue 12, 7524-7530, Apr, 1991

The isolation and identification of multiple forms of the neutrophil granule peptides from human leukemic cells

A Bateman, A Singh, C Shustik, WM Mars and S Solomon
Department of Medicine, Obstetrics, and Gynecology, Royal Victoria Hospital/McGill University, Montreal, Quebec, Canada.

HP-1 is a 30-residue cysteine- and arginine-rich peptide of the human neutrophil primary granule and is the most abundant human representative of the family of peptides variously called defensins and corticostatins. Peptides belonging to this family have many biological activities including the non-oxidative destruction of ingested microorganisms, the inhibition of adrenocorticotropin-stimulated synthesis of glucocorticoids, monocyte chemotaxis, the non-cytolytic inhibition of [3H]thymidine incorporation in HL-60 promyelocyte-like cells and the stimulation of nifedipine-sensitive calcium channels. Using a combination of reversed-phase and size-exclusion high performance liquid chromatography and an HP-1 radio-immunoassay, three immunoreactive peptides were detected and isolated from the promyelocyte-like cell line, HL-60, and from leukocytes of patients with chronic myelogenous and chronic lymphocytic leukemias. One of these peptides was HP-1 itself. A second was identified by gas-phase Edman microsequencing as an amino-terminally extended fragment of the HP-1 precursor which we call HP1-56. The third is likely to arise from enzymatic cleavage of the precursor at a dibasic site. Of the leukemic cells the greatest amount of HP1-56 relative to HP-1 was found in cells from a patient in myeloblastic crisis but overall the richest source of HP1-56 relative to HP-1 was found to be in fetal lung tissue. HP1-56 is difficult to detect in normal peripheral neutrophils and its presence in cells that are actively biosynthesizing primary granule components such as HL-60 may make it useful for studying the biosynthesis of granule polypeptides, their ontogeny, and possibly as a marker protein for leukemic diseases.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Yaneva, S. Kippenberger, N. Wang, Q. Su, M. McGarvey, A. Nazarian, L. Lacomis, H. Erdjument-Bromage, and P. Tempst PU.1 and a TTTAAA Element in the Myeloid Defensin-1 Promoter Create an Operational TATA Box That Can Impose Cell Specificity onto TFIID Function. J. Immunol., June 1, 2006; 176(11): 6906 - 6917. [Abstract] [Full Text] [PDF]

				J. Li, J. Zhao, X. Yu, J. Lange, H. Kuerer, S. Krishnamurthy, E. Schilling, S. A. Khan, S. Sukumar, and D. W. Chan Identification of Biomarkers for Breast Cancer in Nipple Aspiration and Ductal Lavage Fluid Clin. Cancer Res., December 1, 2005; 11(23): 8312 - 8320. [Abstract] [Full Text] [PDF]

				D. J. Lynn, A. T. Lloyd, M. A. Fares, and C. O'Farrelly Evidence of Positively Selected Sites in Mammalian {alpha}-Defensins Mol. Biol. Evol., May 1, 2004; 21(5): 819 - 827. [Abstract] [Full Text] [PDF]

				S. P. Concannon, T. D. Crowe, J. J. Abercrombie, C. M. Molina, P. Hou, D. K. Sukumaran, P. A. Raj, and K. -P. Leung Susceptibility of oral bacteria to an antimicrobial decapeptide J. Med. Microbiol., December 1, 2003; 52(12): 1083 - 1093. [Abstract] [Full Text] [PDF]

				T. M. Halder, M. Bluggel, S. Heinzel, G. Pawelec, H. E. Meyer, and H. Kalbacher Defensins are dominant HLA-DR-associated self-peptides from CD34- peripheral blood mononuclear cells of different tumor patients (plasmacytoma, chronic myeloid leukemia) Blood, May 1, 2000; 95(9): 2890 - 2896. [Abstract] [Full Text] [PDF]

				C L BEVINS, E MARTIN-PORTER, and T GANZ Defensins and innate host defence of the gastrointestinal tract Gut, December 1, 1999; 45(6): 911 - 915. [Full Text] [PDF]

				Y. Ma, Q. Su, and P. Tempst Differentiation-stimulated Activity Binds an ETS-like, Essential Regulatory Element in the Human Promyelocytic defensin-1 Promoter J. Biol. Chem., April 10, 1998; 273(15): 8727 - 8740. [Abstract] [Full Text] [PDF]

				A. A.-R. Higazi, I. I. Barghouti, and R. Abu-Much Identification of an Inhibitor of Tissue-type Plasminogen Activator-mediated Fibrinolysis in Human Neutrophils J. Biol. Chem., April 21, 1995; 270(16): 9472 - 9477. [Abstract] [Full Text] [PDF]